Takeda Pharmaceutical Co Ltd 2023 SR
The report outlines Takeda Brazil's operational strategy and performance for the fiscal year 2022, focusing on its three imperatives: Patients, People, and the Planet. Key highlights include the approval of a dengue vaccine by Anvisa, reaching a 40% greenhouse gas emissions reduction target ahead of schedule, and supporting over 10,700 patients through support programs. The company also emphasized its commitment to diversity, equity, and inclusion, achieving recognition as a Top Employer and Great Place to Work. Additionally, Takeda established a new Data, Digital & Technology department to drive digital transformation and operational efficiency.
Company: Takeda Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: SR
Pages: 68
Takeda Pharmaceutical Co Ltd
The report outlines Takeda Brazil's operational strategy and performance for the fiscal year 2022, focusing on its three imperatives: Patients, People, and the Planet. Key highlights include the approval of a dengue vaccine by Anvisa, reaching a 40% greenhouse gas emissions reduction target ahead of schedule, and supporting over 10,700 patients through support programs. The company also emphasized its commitment to diversity, equity, and inclusion, achieving recognition as a Top Employer and Great Place to Work. Additionally, Takeda established a new Data, Digital & Technology department to drive digital transformation and operational efficiency.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees